30 Oct 2018 11:37
Β
Β
Β
For immediate release: 30 October 2018
Β
Accrol Group Holdings plc
("Accrol Group" or the "Company")
AIM: ACRL
Β
Result of Annual General Meeting
Β
Β
Β
Accrol Group Holdings Plc (AIM: ACRL), the AIM-listed leading independent tissue converter, announces that at the Annual General Meeting of the Company held earlier today, all resolutions put to shareholders were duly passed.
Β
Β
Β
Β
Β
For further information, please contact: | Β |
Β | Β |
Accrol Group Holdings plc | Β |
Dan Wright, Executive Chairman | Tel: +44 (0) 1254 278 844 |
Gareth Jenkins, Chief Executive Officer | Β |
Steve Townsley, Chief Financial Officer | Β |
Β | Β |
Zeus Capital Limited (Nominated Adviser & Broker)Β | Β |
Dan Bate / Andrew Jones | Tel: +44 (0) 161 831 1512 |
Dominic King / John Goold | Tel: +44 (0) 203 829 5000 |
Belvedere Communications Limited | Β |
Cat Valentine | Β |
Llew Angus (langus@belvederepr.com) | Tel: +44 (0) 7407 023 147 |
Β
Β
Notes to Editors
Β
Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK.Β
Β
Accrol operates from three sites:
Β
Β· A manufacturing, storage and distribution facility in Blackburn;
Β· A facial tissue plant, also in Blackburn; and
Β· A manufacturing, storage and distribution facility in Leyland.
Β
Follow the stocks